{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:28:54Z","timestamp":1774571334108,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s11920-023-01411-1","type":"journal-article","created":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T13:10:21Z","timestamp":1674911421000},"page":"113-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Selective Serotonin Reuptake Inhibitor (SSRI) Bleeding Risk: Considerations for the Consult-Liaison Psychiatrist"],"prefix":"10.1007","volume":"25","author":[{"given":"Daniel","family":"McFarland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhisek","family":"Khandai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Mojtahedzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Ghosn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Hirst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermioni","family":"Amonoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Depti","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shehzad","family":"Niazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Brandstetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Gleason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrett","family":"Key","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara Lubrano","family":"di Ciccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,28]]},"reference":[{"key":"1411_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.phrs.2016.08.017","volume":"118","author":"S Laporte","year":"2017","unstructured":"\u2022 Laporte S, Chapelle C, Caillet P, Beyens MN, Bellet F, Delavenne X, et al. Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: a meta-analysis of observational studies. Pharmacol Res. 2017;118:19\u201332. This meta-analysis demonstrates all-sites elevated risk of bleeding from SSRI antidepressant medications.","journal-title":"Pharmacol Res"},{"issue":"12","key":"1411_CR2","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.4088\/JCP.09r05786blu","volume":"71","author":"C Andrade","year":"2010","unstructured":"\u2022\u2022 Andrade C, Sandarsh S, Chethan KB, Nagesh KS. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry. 2010;71(12):1565\u201375. Bleeding risk from SSRI antidepressants is highest for gastrointestinal types of bleeding which is roughly double from other sites of bleeding.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"1411_CR3","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/ajg.2014.82","volume":"109","author":"R Anglin","year":"2014","unstructured":"Anglin R, Yuan Y, Moayyedi P, Tse F, Armstrong D, Leontiadis GI. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109(6):811\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1411_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/07853890.2021.2017474","volume":"54","author":"S Nochaiwong","year":"2022","unstructured":"Nochaiwong S, Ruengorn C, Awiphan R, Chai-Adisaksopha C, Tantraworasin A, Phosuya C, et al. Use of serotonin reuptake inhibitor antidepressants and the risk of bleeding complications in patients on anticoagulant or antiplatelet agents: a systematic review and meta-analysis. Ann Med. 2022;54(1):80\u201397.","journal-title":"Ann Med"},{"issue":"1","key":"1411_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cgh.2014.06.021","volume":"13","author":"HY Jiang","year":"2015","unstructured":"\u2022 Jiang HY, Chen HZ, Hu XJ, Yu ZH, Yang W, Deng M, et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;13(1):42-50.e3. The risk of upper GI bleeding may be mitigated by antiacid medication.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"1411_CR6","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s00415-014-7251-9","volume":"261","author":"D Shin","year":"2014","unstructured":"Shin D, Oh YH, Eom CS, Park SM. Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis. J Neurol. 2014;261(4):686\u201395.","journal-title":"J Neurol"},{"issue":"3","key":"1411_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/pds.3632","volume":"24","author":"I Singh","year":"2015","unstructured":"Singh I, Achuthan S, Chakrabarti A, Rajagopalan S, Srinivasan A, Hota D. Influence of pre-operative use of serotonergic antidepressants (SADs) on the risk of bleeding in patients undergoing different surgical interventions: a meta-analysis. Pharmacoepidemiol Drug Saf. 2015;24(3):237\u201345.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1411_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jpsychires.2016.09.001","volume":"83","author":"HY Jiang","year":"2016","unstructured":"Jiang HY, Xu LL, Li YC, Deng M, Peng CT, Ruan B. Antidepressant use during pregnancy and risk of postpartum hemorrhage: a systematic review and meta-analysis. J Psychiatr Res. 2016;83:160\u20137.","journal-title":"J Psychiatr Res"},{"key":"1411_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jad.2017.08.002","volume":"225","author":"KS Na","year":"2018","unstructured":"Na KS, Jung HY, Cho SJ, Cho SE. Can we recommend mirtazapine and bupropion for patients at risk for bleeding?: a systematic review and meta-analysis. J Affect Disord. 2018;225:221\u20136.","journal-title":"J Affect Disord"},{"issue":"1","key":"1411_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0195-5616(88)50003-7","volume":"18","author":"GC Troy","year":"1988","unstructured":"Troy GC. An overview of hemostasis. Vet Clin North Am Small Anim Pract. 1988;18(1):5\u201320.","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"1","key":"1411_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.31887\/DCNS.2007.9.1\/dhalperin","volume":"9","author":"D Halperin","year":"2007","unstructured":"Halperin D, Reber G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci. 2007;9(1):47\u201359.","journal-title":"Dialogues Clin Neurosci"},{"issue":"2","key":"1411_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/cvr\/cvp205","volume":"84","author":"I Lopez-Vilchez","year":"2009","unstructured":"Lopez-Vilchez I, Diaz-Ricart M, White JG, Escolar G, Galan AM. Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake. Cardiovasc Res. 2009;84(2):309\u201316.","journal-title":"Cardiovasc Res"},{"issue":"2 Suppl","key":"1411_CR13","doi-asserted-by":"publisher","first-page":"2S","DOI":"10.1016\/S0893-133X(99)00031-7","volume":"21","author":"PM Whitaker-Azmitia","year":"1999","unstructured":"Whitaker-Azmitia PM. The discovery of serotonin and its role in neuroscience. Neuropsychopharmacology. 1999;21(2 Suppl):2S-8S.","journal-title":"Neuropsychopharmacology"},{"issue":"4306","key":"1411_CR14","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/169800b0","volume":"169","author":"V Erspamer","year":"1952","unstructured":"Erspamer V, Asero B. Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature. 1952;169(4306):800\u20131.","journal-title":"Nature"},{"issue":"8","key":"1411_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/00001721-199711000-00006","volume":"8","author":"N Li","year":"1997","unstructured":"Li N, Wallen NH, Ladjevardi M, Hjemdahl P. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis. 1997;8(8):517\u201323.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"10","key":"1411_CR16","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1056\/NEJM199103073241001","volume":"324","author":"P Golino","year":"1991","unstructured":"Golino P, Piscione F, Willerson JT, Cappelli-Bigazzi M, Focaccio A, Villari B, et al. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med. 1991;324(10):641\u20138.","journal-title":"N Engl J Med"},{"issue":"15","key":"1411_CR17","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.lfs.2007.08.020","volume":"81","author":"EL Pedrazza","year":"2007","unstructured":"Pedrazza EL, Senger MR, Rico EP, Zimmermann FF, Pedrazza L, de Freitas Sarkis JJ, et al. Fluoxetine and nortriptyline affect NTPDase and 5\u2019-nucleotidase activities in rat blood serum. Life Sci. 2007;81(15):1205\u201310.","journal-title":"Life Sci"},{"issue":"10","key":"1411_CR18","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1176\/ajp.153.10.1313","volume":"153","author":"DL Musselman","year":"1996","unstructured":"Musselman DL, Tomer A, Manatunga AK, Knight BT, Porter MR, Kasey S, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry. 1996;153(10):1313\u20137.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"1411_CR19","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/archpsyc.57.9.875","volume":"57","author":"DL Musselman","year":"2000","unstructured":"Musselman DL, Marzec UM, Manatunga A, Penna S, Reemsnyder A, Knight BT, et al. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry. 2000;57(9):875\u201382.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"1411_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1067\/mcp.2000.110456","volume":"68","author":"N Hergovich","year":"2000","unstructured":"Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther. 2000;68(4):435\u201342.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"1411_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/2230-8229.97494","volume":"14","author":"LA Bashawri","year":"2007","unstructured":"Bashawri LA, Ahmed MA. The approach to a patient with a bleeding disorder: for the primary care physician. J Family Community Med. 2007;14(2):53\u20138.","journal-title":"J Family Community Med"},{"issue":"7","key":"1411_CR22","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.4088\/JCP.v68n0707","volume":"68","author":"KA Martin","year":"2007","unstructured":"Martin KA, Krahn LE, Balan V, Rosati MJ. Selective serotonin reuptake inhibitors in the context of hepatitis C infection: reexamining the risks of bleeding. J Clin Psychiatry. 2007;68(7):1024\u20136.","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"1411_CR23","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.4088\/JCP.v64n1215","volume":"64","author":"RM Weinrieb","year":"2003","unstructured":"Weinrieb RM, Auriacombe M, Lynch KG, Chang KM, Lewis JD. A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients. J Clin Psychiatry. 2003;64(12):1502\u201310.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"1411_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2036.2007.03541.x","volume":"27","author":"YK Loke","year":"2008","unstructured":"Loke YK, Trivedi AN, Singh S. Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2008;27(1):31\u201340.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"1411_CR25","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1592\/phco.26.9.1307","volume":"26","author":"JR Mort","year":"2006","unstructured":"Mort JR, Aparasu RR, Baer RK. Interaction between selective serotonin reuptake inhibitors and nonsteroidal antiinflammatory drugs: review of the literature. Pharmacotherapy. 2006;26(9):1307\u201313.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"1411_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.21037\/apm.2017.11.01","volume":"7","author":"C Johnstone","year":"2018","unstructured":"Johnstone C, Rich SE. Bleeding in cancer patients and its treatment: a review. Ann Palliat Med. 2018;7(2):265\u201373.","journal-title":"Ann Palliat Med"},{"issue":"7","key":"1411_CR27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ajh.25494","volume":"94","author":"DE Angelini","year":"2019","unstructured":"Angelini DE, Radivoyevitch T, McCrae KR, Khorana AA. Bleeding incidence and risk factors among cancer patients treated with anticoagulation. Am J Hematol. 2019;94(7):780\u20135.","journal-title":"Am J Hematol"},{"issue":"3","key":"1411_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/sj.bjc.6606074","volume":"104","author":"NB Leighl","year":"2011","unstructured":"Leighl NB, Bennouna J, Yi J, Moore N, Hambleton J, Hurwitz H. Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on study. Br J Cancer. 2011;104(3):413\u20138.","journal-title":"Br J Cancer"},{"key":"1411_CR29","doi-asserted-by":"publisher","first-page":"e004587","DOI":"10.1136\/bmjopen-2013-004587","volume":"4","author":"S Narum","year":"2014","unstructured":"Narum S, Westergren T, Klemp M. Corticosteroids and risk of gastrointestinal bleeding: a systematic reivew and meta-analysis. BMJ Open. 2014;4:e004587.","journal-title":"BMJ Open"},{"issue":"7","key":"1411_CR30","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/01.TP.0000438212.72960.ae","volume":"97","author":"J Chilcot","year":"2014","unstructured":"Chilcot J, Spencer BW, Maple H, Mamode N. Depression and kidney transplantation. Transplantation. 2014;97(7):717\u201321.","journal-title":"Transplantation"},{"issue":"9","key":"1411_CR31","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1016\/j.transproceed.2012.09.085","volume":"44","author":"M Esmat Gamil","year":"2012","unstructured":"Esmat Gamil M, Pirenne J, Van Malenstein H, Verhaegen M, Desschans B, Monbaliu D, et al. Risk factors for bleeding and clinical implications in patients undergoing liver transplantation. Transplant Proc. 2012;44(9):2857\u201360.","journal-title":"Transplant Proc"},{"issue":"5","key":"1411_CR32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/00062752-200109000-00009","volume":"8","author":"S Nevo","year":"2001","unstructured":"Nevo S, Vogelsang GB. Acute bleeding complications in patients after bone marrow transplantation. Curr Opin Hematol. 2001;8(5):319\u201325.","journal-title":"Curr Opin Hematol"},{"key":"1411_CR33","unstructured":"Labbate LA, Fava M, Rosenbaum JF, Arana GW. Drugs for the treatment of depression. Handbook of Psychiatric Drug Therapy Philidelphia, PA: Lippincott Williams & Wilkins; 2010. p. 54."},{"issue":"1","key":"1411_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.14218\/JERP.2015.00001","volume":"1","author":"A Anbarlou","year":"2016","unstructured":"Anbarlou A, Rahnama MA, Atashi A, Soleimani M. Selective serotonin reuptake inhibitors may improve the efficacy of hematopoietic stem cells transplantation. J Exp Res Pharm. 2016;1(1):16\u20139.","journal-title":"J Exp Res Pharm"},{"issue":"7","key":"1411_CR35","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1161\/STROKEAHA.114.005302","volume":"45","author":"JK Mortensen","year":"2014","unstructured":"Mortensen JK, Larsson H, Johnsen SP, Andersen G. Impact of prestroke selective serotonin reuptake inhibitor treatment on stroke severity and mortality. Stroke. 2014;45(7):2121\u20133.","journal-title":"Stroke"},{"issue":"9","key":"1411_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","volume":"22","author":"U Dirnagl","year":"1999","unstructured":"Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22(9):391\u20137.","journal-title":"Trends Neurosci"},{"issue":"3","key":"1411_CR37","first-page":"e28","volume":"129","author":"AS Go","year":"2014","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics\u20132014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28\u2013292.","journal-title":"Circulation"},{"issue":"11","key":"1411_CR38","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","volume":"372","author":"M Goyal","year":"2015","unstructured":"Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019\u201330.","journal-title":"N Engl J Med"},{"issue":"3","key":"1411_CR39","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1161\/STROKEAHA.112.673947","volume":"44","author":"GE Mead","year":"2013","unstructured":"Mead GE, Hsieh CF, Lee R, Kutlubaev M, Claxton A, Hankey GJ, et al. Selective serotonin reuptake inhibitors for stroke recovery: a systematic review and meta-analysis. Stroke. 2013;44(3):844\u201350.","journal-title":"Stroke"},{"key":"1411_CR40","unstructured":"Ehrenborg A. A study of the increased ris of bleeding events in patients with blood clotting disorders associated with antidepressant medication use. Open Access Master Thesis. 2016;840."},{"issue":"11","key":"1411_CR41","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1111\/bcp.14833","volume":"87","author":"M Wang","year":"2021","unstructured":"Wang M, Zeraatkar D, Obeda M, Lee M, Garcia C, Nguyen L, et al. Drug-drug interactions with warfarin: a systematic review and meta-analysis. Br J Clin Pharmacol. 2021;87(11):4051\u2013100.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"1411_CR42","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3349\/ymj.2020.61.9.741","volume":"61","author":"MT Lee","year":"2020","unstructured":"Lee MT, Park KY, Kim MS, You SH, Kang YJ, Jung SY. Concomitant use of NSAIDs or SSRIs with NOACs requires monitoring for bleeding. Yonsei Med J. 2020;61(9):741\u20139.","journal-title":"Yonsei Med J"},{"issue":"1","key":"1411_CR43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/cpt.1603","volume":"107","author":"JJ Komen","year":"2020","unstructured":"Komen JJ, Hjemdahl P, Mantel-Teeuwisse AK, Klungel OH, Wettermark B, Forslund T. Concomitant anticoagulant and antidepressant therapy in atrial fibrillation patients and risk of stroke and bleeding. Clin Pharmacol Ther. 2020;107(1):287\u201394.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"1411_CR44","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s40801-021-00260-9","volume":"8","author":"RHC Zeiss","year":"2021","unstructured":"Zeiss RHC, Gahr M. Risk of bleeding associated with antidepressant drugs: the competitive impact of antithrombotics in quantitative signal detection. Drugs-Real World Outcomes. 2021;8(4):547\u201354.","journal-title":"Drugs-Real World Outcomes"},{"issue":"6","key":"1411_CR45","doi-asserted-by":"publisher","first-page":"e21447","DOI":"10.1371\/journal.pone.0021447","volume":"6","author":"H Schelleman","year":"2011","unstructured":"Schelleman H, Brensinger CM, Bilker WB, Hennessy S. Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control study. PLoS ONE. 2011;6(6):e21447.","journal-title":"PLoS ONE"},{"issue":"5","key":"1411_CR46","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/pds.1737","volume":"18","author":"SM Wallerstedt","year":"2009","unstructured":"Wallerstedt SM, Gleerup H, Sundstr\u00f6m A, Stigendal L, Ny L. Risk of clinically relevant bleeding in warfarin-treated patients\u2013influence of SSRI treatment. Pharmacoepidemiol Drug Saf. 2009;18(5):412\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"1411_CR47","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/01.jcp.0000186869.67418.bc","volume":"25","author":"PA Kurdyak","year":"2005","unstructured":"Kurdyak PA, Juurlink DN, Kopp A, Herrmann N, Mamdani MM. Antidepressants, warfarin, and the risk of hemorrhage. J Clin Psychopharmacol. 2005;25(6):561\u20134.","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"1411_CR48","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00228-020-02856-6","volume":"76","author":"DM Rydberg","year":"2020","unstructured":"Rydberg DM, Linder M, Malmstr\u00f6m RE, Andersen M. Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication. Eur J Clin Pharmacol. 2020;76(6):867\u201376.","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"1411_CR49","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1177\/1078155220901569","volume":"26","author":"HK Ng","year":"2020","unstructured":"Ng HK, Rogala BG, Ades S, Schwartz JR, Ashikaga T, Vacek P, et al. Prospective evaluation of drug-drug interactions in ambulatory cancer patients initiated on prophylactic anticoagulation. J Oncol Pharm Pract. 2020;26(7):1637\u201342.","journal-title":"J Oncol Pharm Pract"},{"issue":"10","key":"1411_CR50","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/pds.2219","volume":"20","author":"AI Vitry","year":"2011","unstructured":"Vitry AI, Roughead EE, Ramsay EN, Preiss AK, Ryan P, Gilbert AL, et al. Major bleeding risk associated with warfarin and co-medications in the elderly population. Pharmacoepidemiol Drug Saf. 2011;20(10):1057\u201363.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"1411_CR51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/pnp.311","volume":"17","author":"S Bleakley","year":"2013","unstructured":"Bleakley S. Review of the choice and use of antidepressant drugs. Prog Neurol Psychiatry. 2013;17(6):18\u201326.","journal-title":"Prog Neurol Psychiatry"},{"key":"1411_CR52","unstructured":"Excellence NIfHaC. Depression in adults. Clinical Guideline CG90 2009.\u00a0Available from: http:\/\/guidance.nice.org.uk\/CG90.\u00a0Accessed 30 Sept 2022.\u00a0"},{"issue":"3","key":"1411_CR53","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.psc.2016.04.010","volume":"39","author":"C Andrade","year":"2016","unstructured":"\u2022 Andrade C, Sharma E. Serotonin reuptake inhibitors and risk of abnormal bleeding. Psychiatr Clin North Am. 2016;39(3):413\u201326. This review demonstrates the differential effect of antidepressant class -based bleeding risk.","journal-title":"Psychiatr Clin North Am"},{"issue":"21","key":"1411_CR54","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1001\/archinte.164.21.2367","volume":"164","author":"WE Meijer","year":"2004","unstructured":"Meijer WE, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, Egberts AC. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med. 2004;164(21):2367\u201370.","journal-title":"Arch Intern Med"},{"issue":"4","key":"1411_CR55","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000319744","volume":"86","author":"R Schellander","year":"2010","unstructured":"Schellander R, Donnerer J. Antidepressants: clinically relevant drug interactions to be considered. Pharmacology. 2010;86(4):203\u201315.","journal-title":"Pharmacology"},{"issue":"6","key":"1411_CR56","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.amjmed.2006.10.026","volume":"120","author":"RC Ziegelstein","year":"2007","unstructured":"Ziegelstein RC, Meuchel J, Kim TJ, Latif M, Alvarez W, Dasgupta N, et al. Selective serotonin reuptake inhibitor use by patients with acute coronary syndromes. Am J Med. 2007;120(6):525\u201330.","journal-title":"Am J Med"},{"issue":"16","key":"1411_CR57","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1161\/hc4101.097519","volume":"104","author":"WH Sauer","year":"2001","unstructured":"Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation. 2001;104(16):1894\u20138.","journal-title":"Circulation"},{"issue":"1","key":"1411_CR58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/01.CIR.0000079172.43229.CD","volume":"108","author":"WH Sauer","year":"2003","unstructured":"Sauer WH, Berlin JA, Kimmel SE. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation. 2003;108(1):32\u20136.","journal-title":"Circulation"},{"issue":"5","key":"1411_CR59","doi-asserted-by":"publisher","first-page":"109957","DOI":"10.1016\/j.celrep.2021.109957","volume":"37","author":"J Bi","year":"2021","unstructured":"Bi J, Khan A, Tang J, Armando AM, Wu S, Zhang W, et al. Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug. Cell Rep. 2021;37(5):109957.","journal-title":"Cell Rep"},{"issue":"2","key":"1411_CR60","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.mayocp.2021.11.010","volume":"97","author":"AD Oprea","year":"2022","unstructured":"Oprea AD, Keshock MC, O\u2019Glasser AY, Cummings KC 3rd, Edwards AF, Hunderfund AL, et al. Preoperative management of medications for neurologic diseases: society for perioperative assessment and quality improvement consensus statement. Mayo Clin Proc. 2022;97(2):375\u201396.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"1411_CR61","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/JCP.0000000000000575","volume":"36","author":"SP Roose","year":"2016","unstructured":"Roose SP, Rutherford BR. Selective serotonin reuptake inhibitors and operative bleeding risk: a review of the literature. J Clin Psychopharmacol. 2016;36(6):704\u20139.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"1411_CR62","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000366551","volume":"133","author":"C Schafer","year":"2015","unstructured":"Schafer C, O\u2019Meara A, Tsakiris DA, Medinger M, Passweg JR, Stern M. Influence of selective serotonin reuptake inhibitors on bleeding risk in patients with severe thrombocytopenia after chemotherapy: a retrospective study. Acta Haematol. 2015;133(3):317\u201320.","journal-title":"Acta Haematol"},{"issue":"2","key":"1411_CR63","doi-asserted-by":"publisher","first-page":"19","DOI":"10.21466\/ac.SSRIIBD.2016","volume":"4","author":"G Zahavi","year":"2016","unstructured":"Zahavi G, et al. Selective serotonin reuptake inhibitor induced bleeding disorder in neurosurgical patients-a cause for concern? Anaesthesia Cases. 2016;4(2):19\u201321.","journal-title":"Anaesthesia Cases."},{"key":"1411_CR64","unstructured":"Frimpong JA, Myers CG, Sutcliffe KM, Lu-Myers Y. When health care providers look at problems from multiple perspectives, patients benefit. Harv Bus Rev. 2017."}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-023-01411-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11920-023-01411-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-023-01411-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T19:41:34Z","timestamp":1701805294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11920-023-01411-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,28]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1411"],"URL":"https:\/\/doi.org\/10.1007\/s11920-023-01411-1","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,28]]},"assertion":[{"value":"30 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Additionally, each author met each of the authorship requirements as stated in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Daniel McFarland, Dale Merchant, Abhisek Khandai, Mona Mojtahedzadeh, Omar Ghosn, Jeremy Hirst, Depti Chopra, Shehzad Niazi, Jennifer Brandstetter, Andrew Gleason, Garrett Key, and Barbara Lubrano di Cicconeeach declare no potential conflicts of interest. Hermioni Amonoo has received a grant from the National Cancer Institute.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}